Skip to main content
. 2021 Aug 5;3:100054. doi: 10.1016/j.rcsop.2021.100054

Table 1.

Potentially inappropriate medications risking cognitive impairment (PIMcogn).

ATC-code1 Drugs
H02AB Glucocorticoids
N02A Opioids
N03 Antiepileptics
N04B Dopaminergic agents
N05A excl. N05AN2 Antipsychotics
N05BA/N05CD Benzodiazepine derivatives
A03AB, A03BA, A03BB, A04AD, C01BA, G04BD (excl. G04BD12), M03BC01, M03BC51, N02AG, N04A, N05AA02, N05AB04, N05AF03, N05AH02, N05BB01, N05CM06, N06AA, R06AA02, R06AA04, R06AB, R06AD, R06AE05, R06AX02 Drugs with significant anticholinergic effects (drugs for functional gastrointestinal disorders, antiemetics, class 1a anti-arrhythmic drugs, drugs for urinary frequency and incontinence, muscle relaxants centrally acting agents, opioids in combination with antispasmodics, anticholinergic agents for Parkinson, antipsychotic drugs, anxiolytic drugs, non-selective monoamine reuptake inhibitors, antihistamines for systemic use)
1

ATC-code, Anatomical Therapeutical Chemical classification code.27

2

N05AN (Lithium) excluded in accordance with the Swedish National Board of Health and Welfare.2